Modelling the Effects of Medium-Chain Triglycerides on Cerebral Ketone Body Metabolism
Alzheimer’s Disease (AD) is a neurodegenerative disorder that causes drastic structural brain atrophy and affects multiple brain functions. Cerebral glucose hypometabolism, associated with senile plaque density formation, is a pre-symptomatic feature of AD and significantly contributes to AD’s futur...
Saved in:
Published in | Frontiers in Systems Biology (Online) Vol. 2 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
23.06.2022
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!